McKesson Corporation

• 8-KPositiveListing noticeGuidance withdrawnDeal pending

  Filed Oct 6

  Planned minority stake in Option Care Health’s buyout with CD&R supports expansion of specialty therapy access in community care.

• 8-K

  Filed Aug 28

  Cybersecurity incident discovered Aug. 25 affected McKesson’s information systems; investigation is in its early stages.

• 10-QQ1 FY2027Restructuring

  Filed Aug 5

  Medical-Surgical and Core Ventures redemption-value adjustments outweighed operating gains, reducing earnings for shareholders.

  • Revenue$105.4BYoY +7.7%
  • Net income$614.0MYoY −21.7%

• 8-KPositiveEarningsGuidance raised

  Filed Aug 5

  Higher prescription volumes and specialty distribution fuel North American Pharmaceutical and Oncology & Multispecialty growth, lifting the adjusted EPS outlook.

• 8-KShareholder vote

  Filed Jul 24

  Shareholders elected all director nominees, backed executive pay and ratified Deloitte & Touche as FY2027 auditor.

• 8-KLeadership change

  Filed Jul 1

  Thomas L. Rodgers to retire; Ramesh Srinivasan becomes EVP, Chief Strategy Officer effective Aug. 1, 2026.

Coverage: 10-K, 10-Q and 8-K filings filed since Jul 9, 2026.

Request longer coverage

Company data: Wikidata Q570473